
MimiVax
Developer of immunotherapeutic vaccines and targeted therapies designed to control tumor growth and recurrence. The company's vaccines use surviving-targeting technology to target a cell-survival prot...
Valuation
$0
Share Price
N/A
Total Raised
$21.3M
Last Round
N/A